Sanofi (SANp)

CBOE (Paris)Healthcare

€78.39
+€0.38 (+0.5%)
Last close

January 21, 2026 at 16:30 UTC

Interactive Chart
SANp
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Sanofi

Name

Sanofi

CEO

Paul Hudson

Industry

Healthcare

Year Founded

1973

Employees

82,878

Sanofi is a healthcare company that discovers, manufactures, and supplies medicines and vaccines used in clinical practice. Clinical programs target evidence that can be translated into labeling, and medical information supports safe use after approval. Plants operate to validated procedures, and logistics are planned so pharmacies, hospitals, and clinics receive steady supply. Regional teams handle access and pharmacovigilance under local rules while global functions maintain shared standards. Reporting sits inside the healthcare sector with a focus on operating facts rather than narrative goals. The company describes its role as maintaining continuity for health systems while adding new options through measured change. The stance is process first, with patient safety and data integrity kept at the center of decisions.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 3 Buy, 3 Hold, 18 Sell
Buy3
Hold3
Sell18
Fundamentals & Financials
Revenue (TTM)
€45.9B
Net Income (TTM)
€9.2B
EPS (TTM)
€11.21
ROA (TTM)
7.16%
Current Ratio
1.06
Dividend Yield
0.1%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue€13,170M
Cost of Sales€3,412M
Gross Profit€9,758M
Operating Income€3,623M
Net Income€2,802M
EPS€2.3
Technical Indicators

Sanofi's Technical Indicators Summary

SANp is currently exhibiting a bearish trend, with the price trading below all major moving averages, including the 200-day EMA near 88, signaling sustained downward pressure. Momentum indicators reinforce this view, as the RSI remains low near 33 and the MACD level is negative, reflecting weak buying interest. The ADX value around 26 suggests a moderately strong trend, while the volume-based OBV confirms selling dominance. Although volatility measured by ATR is stable and the price sits just below the VWAP and pivot levels, these do not offset the prevailing weakness. Overall, the technical landscape points to a persistent bearish environment for SANp.

Buy
3 signals
Neutral
3 signals
Sell
18 signals
Overall: Bearish75% Bearish signals
IndicatorValue
RSI (14)
33.34
Stochastic %K (14, 3, 3)
4.01
CCI (20)
-299.73
WPR (14)
-100.00
Momentum (10)
-4.82
MFI
44.36
MACD Level (12, 26)
-1.09
Bollinger Bands
$78.78 - $84.82
ATR (14)
$1.70 (2.19%)
ADX (14)
25.88
OBV
16,932,512
VWAP
$78.13
Classic Pivot Point
$79.35
Fibonacci Pivot Point
$79.35
Simple Moving Averages
$81.44 - $85.40(5 indicators)
Exponential Moving Averages
$80.70 - $87.88(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

SAN.PA opened with a modest lift, gapping up 0.679% to 78.56 from yesterday’s 78.03 close. The first stretch of the session shows barely any flow, with SAN.PA at 0.29× normal volume. SAN.PA's modest increase amid limited volume may reflect cautious trading ahead of upcoming sector news.

Price Change

from €78.03 close

€-0.01

Trading Volume

Below avg (1.8M)

518.1K

vs S&P 500 Today

Outperforming Market

+2.05%

52-Week Position

Near lows

5.4%

Updated: January 21, 2026 at 10:06 UTC

Quote Summary
OpenPrevious Close
€78.56€78.03
Day Range52 Week Range
€77.84 - €78.69€76.15 - €110.88
VolumeAvg. Volume
2.8M1.8M
Market CapP/E Ratio
€94.9B15.0